Artemisinin as a Chinese medicine, selectively induces apoptosis in pancreatic tumor cell line

Chinese Journal of Integrative Medicine

Volumn 20, Issue 8, 2014, Pages 618-623

  Noori, Shokoofe ^a   Hassan, Zuhair M ^b   Farsam, Vida ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

apoptosis; Artemisinin; endoperoxide bridge; reactive oxygen species

Indexed keywords

ARTEMISININ; CASPASE 3; FAS ANTIGEN; FAS LIGAND; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROPIDIUM IODIDE; REACTIVE OXYGEN METABOLITE; ARTEMISININ DERIVATIVE; IRON;

APOPTOSIS; ARTEMISIA ANNUA; ARTICLE; CANCER INHIBITION; CELL GROWTH; CHINESE MEDICINE; COLUMN CHROMATOGRAPHY; CONCENTRATION RESPONSE; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; MTT ASSAY; PANCREAS TUMOR; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; THIN LAYER CHROMATOGRAPHY; TUMOR CELL LINE; CELL PROLIFERATION; COLORIMETRY; DRUG EFFECTS; ENZYMOLOGY; HUMAN; METABOLISM; PATHOLOGY; TIME;

ANNEXIN A5; ANTIGENS, CD95; APOPTOSIS; ARTEMISININS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; COLORIMETRY; FLOW CYTOMETRY; HUMANS; IRON; PANCREATIC NEOPLASMS; PROPIDIUM; PROTON MAGNETIC RESONANCE SPECTROSCOPY; REACTIVE OXYGEN SPECIES; TIME FACTORS;

EID: 84905569503     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-013-1454-2     Document Type: Article

References (25)

1. Klayman DL. Qinghaosu (Artemisinin): an antimalarial drug from China. Science 1985;228:1049-1055. (Pubitemid 15227365)
2. Luo Z, Shen C. The chemistry, pharmacology, and clinical applications of qinghaosu (Artemisinin) and its derivatives. Med Res Rev 1987;7:29-52.
3. Borstnik K, Paik I, Posner G. Malaria: new chemotherapeutic peroxide drugs. Mini-Reviews in Medicinal Chemistry 2002;2:573-583.
4. Meshnick S, Yang Y, Lima V, Kuypers F, Kamchonwongpaisan S, Yuthavong Y. Iron-dependent free radical generation from the antimalarial agent Artemisinin (qinghaosu). Antimicrob Agents Chemother 1993;37:1108-1114. (Pubitemid 23141328)
5. O'Neill P, Posner G. A medicinal chemistry perspective on artemisinin and related endoperoxides. J Med Chem 2004;47:2945-2964. (Pubitemid 38702690)
6. Robert A, Coppel Y, Meunier B. A lkylation of heme by the antimalarial drug Artemisinin. Chem Commun 2002;5:414-415. (Pubitemid 34252451)
7. Sanjeev K, Anne-Catrin U, Richard KH. Artemisinins: mechanisms of action and potential for resistance. Drug Resistance Updates 2004;7:233-244.
8. Nathawut S, Rachanee U, Anake K, Udom C, Samlee M. Redox reaction of Artemisinin with ferrous and ferric ions in aqueous buffer. Chem Pharm Bull 2001;49:1541-1546.
9. Asawamahasakda W, Ittarat I, Pu Y, Ziffer H, Meshnick S. Reaction of antimalarial endoperoxides with specific parasite proteins. Antimicrob Agents Chemother 1994;38:1854-1858. (Pubitemid 24250737)
10. Thompson C. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
11. Soini Y, Paakko P, Lehto V. Histopathological evaluation of apoptosis in cancer. Am J Pathol 1998;153:1041-1053. (Pubitemid 28465828)
12. Chick W, Warren S, Chute R, Like A, Lauris V, Kitchen K. A transplantable insulinoma in the rat. Proc Natl Acad Sci USA 1977;74:628-632. (Pubitemid 8038777)
13. Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar C: The anti-malarial artesunate is also active against cancer. Int J Oncol 2001;18:767-773.
14. Efferth T, Davey M, Olbrich A, Rücher G, Gebbart E, Daveu R. Activity of drugs from traditional Chinese medicine towards sensitive and MDRI- or MRPI-overexpressing multidrug-resistant human CCRF-CEM leukemia cells. Blood Cells Mol Dis 2002;28:160-168. (Pubitemid 34743750)
15. Berman P, Adams P. Artemisinin enhances heme-catalysed oxidation of lipid membranes. Free Radic Bio Med 1997;22:1283-1288. (Pubitemid 27171971)
16. Zhang F, Grosser D, Meshnick S. Hemin-catalyzed decomposition of Artemisinin (qinghaosu). Biochem Pharmacol 1992;43:1805-1809.
17. Singh NP, Lai H. Artemisinin induces apoptosis in human cancer cells. Anticancer Research 2004;24:2277-2280. (Pubitemid 39166306)
18. Kihara C, Tsunoda T, Tanaka T, Yamana H, Furukawa Y, Ono K, et al. Prediction of sensitivity of esophageal tumor to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res 2001;61:6474-6479. (Pubitemid 32783254)
19. Singh N, Lai H. Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. Life Sci 2001;70:49-56. (Pubitemid 33130042)
20. Lai H, Singh N. Selective cancer cell cytotoxicity from exposure to dihydro artemisinin and holotransferrin. Cancer Lett 1995;91:41-46.
21. Price R, van Vugt M, Nosten F, Luxemburger C, Brockman A, Phaipun L, et al. Artesunate versus artemether for the treatment of recrudescent multidrug resistant plasmodium falciparum malaria. Am J Trop Med Hyg 1998;59:883-888. (Pubitemid 29028916)
22. Efferth T, Briehl M, Tome M. Role of antioxidant genes for the activity of artesunate against tumor cells. Int J Oncol 2003;23:1231-1235.
23. Meshnick S. Artemisinin: mechanisms of action, resistance and toxicity. Int J Parasitol 2002;32:1655-1660. (Pubitemid 35339455)
24. Fleury C, Mignotte B, Vayssiere J. Mitochondrial reactive oxygen species in cell death signaling. Biochimie 2002;84:131-141. (Pubitemid 34946949)
25. Li Y, Wu YL. How Chinese scientists discovered qinghaosu (Artemisinin) and developed its derivatives. What are the future perspectives? Med Trop1998,58:9-12. (Pubitemid 128707810)